Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule
- Authors: Shkurnikov M.Y.1,2, Makarova Y.A.1, Knyazev E.N.1,2, Fomicheva K.A.2, Galatenko A.V.1, Nyushko K.M.2, Galatenko V.V.1, Vechorko V.I.3, Alekseev B.Y.2
-
Affiliations:
- BioClinicum Research Centre
- P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
- Federal Research Institute of Health Organization and Informatics, Ministry of Health of the Russian Federation
- Issue: Vol 163, No 4 (2017)
- Pages: 475-477
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239002
- DOI: https://doi.org/10.1007/s10517-017-3831-x
- ID: 239002
Cite item
Abstract
Profiles of circulating microRNA in the plasma of patients with prostate cancer with pathomorphological stages pT2, pT3, and pT4 are analyzed. The level of circulating microRNA hsa-miR-619-5p is elevated in patients with extracapsular spreading of the tumor, increasing significantly from stage pT2 to stage pT4.
About the authors
M. Yu. Shkurnikov
BioClinicum Research Centre; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
Author for correspondence.
Email: mshkurnikov@gmail.com
Russian Federation, Moscow; Moscow
Yu. A. Makarova
BioClinicum Research Centre
Email: mshkurnikov@gmail.com
Russian Federation, Moscow
E. N. Knyazev
BioClinicum Research Centre; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
Email: mshkurnikov@gmail.com
Russian Federation, Moscow; Moscow
K. A. Fomicheva
P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
Email: mshkurnikov@gmail.com
Russian Federation, Moscow
A. V. Galatenko
BioClinicum Research Centre
Email: mshkurnikov@gmail.com
Russian Federation, Moscow
K. M. Nyushko
P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
Email: mshkurnikov@gmail.com
Russian Federation, Moscow
V. V. Galatenko
BioClinicum Research Centre
Email: mshkurnikov@gmail.com
Russian Federation, Moscow
V. I. Vechorko
Federal Research Institute of Health Organization and Informatics, Ministry of Health of the Russian Federation
Email: mshkurnikov@gmail.com
Russian Federation, Moscow
B. Ya. Alekseev
P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
Email: mshkurnikov@gmail.com
Russian Federation, Moscow